75 related articles for article (PubMed ID: 22392265)
1. Selective arterial embolization of giant renal tuberous sclerosis.
De Pasquale V; Natali G; Falappa P; Nappo SG; Salerno A; Caione P
Indian J Pediatr; 2013 Mar; 80(3):263-5. PubMed ID: 22392265
[TBL] [Abstract][Full Text] [Related]
2. Renal angiomyolipomas in tuberous sclerosis--rare but potentially life-threatening lesions.
Azim A; Rajkumar G
BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23242096
[TBL] [Abstract][Full Text] [Related]
3. Consequences of delay in screening, monitoring, and treatment of angiomyolipoma and tuberous sclerosis: A case report
.
Gipson TT
Clin Nephrol; 2018 Jul; 90(1):71-75. PubMed ID: 29701176
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of selective arterial embolisation of renal angiomyolipoma.
Swärd J; Bohlin K; Henrikson O; Lundstam S; Peeker R; Grenabo Bergdahl A
Scand J Urol; 2023 Oct; 58():86-92. PubMed ID: 37909895
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Management of a Wünderlich's Syndrome Secondary to a Giant Ruptured Renal Angiomyolipoma: A Case Report.
Bellouki O; Bakouch M; Ibrahimi A; Boualaoui I; El Aoufir O; Zouaidia F; Benhadda S; El Sayegh H; Nouini Y
Urology; 2024 Feb; 184():e246-e249. PubMed ID: 38043904
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update.
Osawa T; Oya M; Okanishi T; Kuwatsuru R; Kawano H; Tomita Y; Niida Y; Nonomura N; Hatano T; Fujii Y; Mizuguchi M; Shinohara N
Int J Urol; 2023 Oct; 30(10):808-817. PubMed ID: 37278492
[TBL] [Abstract][Full Text] [Related]
7. Core needle biopsy and embolization of fat-poor renal tumors in children with tuberous sclerosis complex.
Roebuck DJ; Chippington S; Berry BD; Gibson C
World J Pediatr; 2023 Jun; 19(6):614-618. PubMed ID: 36795318
[No Abstract] [Full Text] [Related]
8. Malignant renal angiomyolipoma: A giant abdominal disease entity.
Gao Z; Tang W; Jiang L; Cang Y
Asian J Surg; 2023 Nov; 46(11):5258-5259. PubMed ID: 37537037
[No Abstract] [Full Text] [Related]
9. Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.
Mekahli D; Müller RU; Marlais M; Wlodkowski T; Haeberle S; de Argumedo ML; Bergmann C; Breysem L; Fladrowski C; Henske EP; Janssens P; Jouret F; Kingswood JC; Lattouf JB; Lilien M; Maleux G; Rozenberg M; Siemer S; Devuyst O; Schaefer F; Kwiatkowski DJ; Rouvière O; Bissler J
Nat Rev Nephrol; 2024 Jun; 20(6):402-420. PubMed ID: 38443710
[TBL] [Abstract][Full Text] [Related]
10. Endovascular management of bilateral renal angiomyolipoma in a perimenopausal woman.
Gowda GG; Tigga M; Ramesh RB
J Vasc Bras; 2023; 22():e20200067. PubMed ID: 37790893
[TBL] [Abstract][Full Text] [Related]
11. Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review.
Bissler JJ; Kingswood JC
Ther Adv Urol; 2016 Aug; 8(4):279-290. PubMed ID: 27928430
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?
Pilotto S; Kinspergher S; Peretti U; Calio A; Carbognin L; Ferrara R; Brunelli M; Chilosi M; Tortora G; Bria E
Anticancer Agents Med Chem; 2015; 15(3):307-13. PubMed ID: 25382117
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition.
Krummel T; Garnon J; Lang H; Gangi A; Hannedouche T
BMC Urol; 2014 Sep; 14():77. PubMed ID: 25258166
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint inhibitors in NSCLC.
Johnson DB; Rioth MJ; Horn L
Curr Treat Options Oncol; 2014 Dec; 15(4):658-69. PubMed ID: 25096781
[TBL] [Abstract][Full Text] [Related]
15. Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.
Siroky BJ; Yin H; Dixon BP; Reichert RJ; Hellmann AR; Ramkumar T; Tsuchihashi Z; Bunni M; Dillon J; Bell PD; Sampson JR; Bissler JJ
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F560-70. PubMed ID: 24920756
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.
Efstathiou E; Titus M; Wen S; Hoang A; Karlou M; Ashe R; Tu SM; Aparicio A; Troncoso P; Mohler J; Logothetis CJ
Eur Urol; 2015 Jan; 67(1):53-60. PubMed ID: 24882673
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analyses of bilateral renal angiomyolipomas associated with tuberous sclerosis complex].
Huang Z; Li H; Ji Z; Xiao H
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):935-7. PubMed ID: 24854916
[TBL] [Abstract][Full Text] [Related]
18. Emergency embolization of actively bleeding renal angiomyolipoma in a patient of tuberous sclerosis.
Parekh S; Jolapara M; Shah T; Rajpura H
Ren Fail; 2014 Aug; 36(7):1114-8. PubMed ID: 24845549
[TBL] [Abstract][Full Text] [Related]
19. Nephron sparing surgery for renal angiomyolipoma with inferior vena cava thrombus in tuberous sclerosis.
Riviere A; Bessede T; Patard JJ
Case Rep Urol; 2014; 2014():285613. PubMed ID: 24778892
[TBL] [Abstract][Full Text] [Related]
20. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
Kingswood JC; Jozwiak S; Belousova ED; Frost MD; Kuperman RA; Bebin EM; Korf BR; Flamini JR; Kohrman MH; Sparagana SP; Wu JY; Brechenmacher T; Stein K; Berkowitz N; Bissler JJ; Franz DN
Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
